secwatch.observer — SEC 8-K summary
======================================

Issuer:     Covista Inc. (CVSA)
CIK:        0000730464
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0001157523-24-000136
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adtalem Q2 revenue +8.4% to $393.2M, raises FY guidance; short seller report disclosed
--------------------------------------------------------------------------------

- Revenue $393.2M (+8.4% YoY); total enrollment 81,772 (+6.2%); Chamberlain enrollment +6.6%, Walden +7.9%.
- Diluted EPS $0.98; adjusted EPS $1.23 (+5.1% YoY); adjusted EBITDA $92.6M (+2.2%); margin 23.5%.
- FY2024 guidance raised: revenue $1,520-$1,560M (from $1,470-$1,530M); adj. EPS $4.55-$4.75 (from $4.25-$4.45).
- Completed $300M buyback; new $300M authorization through Jan 2027; repaid $50M Term Loan B; repriced $253M at 50bps lower; net leverage 1.5x.
- Filed risk factor re: short seller report published Jan 30 alleging misconduct; share price impacted; may lead to litigation/regulatory probes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730464/000115752324000136/0001157523-24-000136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730464/000115752324000136/a53889834.htm
  HTML page:      https://secwatch.observer/filing/0001157523-24-000136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer